Evaluate at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Evaluate takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions cover AI in the lab and how to build a competitive European biotech community. One asks why the efficiency AI brings could mean more drugs rather than fewer research jobs, and Evaluate also sponsors the meeting.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Evaluate London, United Kingdom | ◆Platinum Sponsor |
Provides pharmaceutical market intelligence, including sales forecasts, pipeline and deal data. | Panel Mon Nov 9 17:00–17:45 AI in the Lab: Why Greater Efficiency Could Mean More Drugs, Not Fewer Scientists Why AI that forms hypotheses and guides experiments could mean more drug candidates, not fewer scientists, and how to pick which to pursue. Ecosystem InnovationBusiness of Biotech Keynote Mon Nov 9 12:00–12:45 Building a competitive and impactful European biotech community: Perspectives from the European Life Sciences Coalition and CEOs How Europe can keep biotech talent, money and companies at home by drawing in big investors, speeding regulation and building stronger stock markets. Ecosystem InnovationBusiness of Biotech |
Instantly find 20 buyers from Evaluate
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction